Azulfidine and C-reactive protein increased - a phase IV clinical study of FDA data
C-reactive protein increased is found among people who take Azulfidine, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Azulfidine and have C-reactive protein increased. It is created by eHealthMe based on reports of 7,443 people who have side effects when taking Azulfidine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
7,443 people reported to have side effects when taking Azulfidine.
Among them, 113 people (1.52%) have C-reactive protein increased.
What is Azulfidine?
Azulfidine has active ingredients of sulfasalazine. It is often used in rheumatoid arthritis. eHealthMe is studying from 7,543 Azulfidine users for its effectiveness, alternative drugs and more.
What is C-reactive protein increased?
C-reactive protein increased is found to be associated with 2,114 drugs and 2,153 conditions by eHealthMe.
Number of Azulfidine and C-reactive protein increased reports submitted per year:
Time on Azulfidine when people have C-reactive protein increased *:
Gender of people who have C-reactive protein increased when taking Azulfidine*:
Age of people who have C-reactive protein increased when taking Azulfidine *:
Common drugs people take besides Azulfidine *:
Common side effects people have besides C-reactive protein increased *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Azulfidine and have C-reactive protein increased?Check whether C-reactive protein increased is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was C-reactive protein increased and when was it recovered:
Expand to all the drugs that have ingredients of sulfasalazine:
Alternative drugs to, pros and cons of Azulfidine:
- Azulfidine (7,543 reports)
Common Azulfidine side effects:
Browse all side effects of Azulfidine:a b c d e f g h i j k l m n o p q r s t u v w x y z
C-reactive protein increased treatments and more:
- C-reactive protein increased (44,057 reports)
COVID vaccines that are related to C-reactive protein increased:
- C-reactive protein increased in Moderna COVID Vaccine
- C-reactive protein increased in Pfizer BioNTech Covid Vaccine
- C-reactive protein increased in Johnson and Johnson Covid Vaccine
Common drugs associated with C-reactive protein increased:
All the drugs that are associated with C-reactive protein increased:
- C-reactive protein increased (2,114 drugs)
Common conditions associated with C-reactive protein increased:
All the conditions that are associated with C-reactive protein increased:
- C-reactive protein increased (2,153 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on sulfasalazine (the active ingredients of Azulfidine) and Azulfidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Folic Acid and Epilepsy - now
- Mirtazapine and Atomoxetine Hydrochloride drug interaction - 2 seconds ago
- Telmisartan and Mental Status Changes - 4 seconds ago
- Constulose and Cardiac Failure - 6 seconds ago
- Sertraline Hydrochloride and Radiculitis Lumbosacral - 10 seconds ago
- Effexor Xr and Homicidal Ideation - 10 seconds ago
- Muscle Spasticity Aggravated and Attention Deficit Hyperactivity Disorder - 13 seconds ago
- Muscle Spasticity Aggravated and Attention Deficit/Hyperactivity Disorder - 13 seconds ago
- Loxapine and Urination - Painful - 16 seconds ago
- Neulasta and Megace Es drug interaction - 19 seconds ago